MetLife Shares Rise 2.15% as Trading Volume Surges 41.77% to $330M Ranking 421st in Activity

Market Snapshot

MetLife (MET) shares rose 2.15% on February 10, 2026, closing at a price that reflected strong investor confidence. Trading volume surged by 41.77% to $0.33 billion, ranking the stock 421st in terms of activity on the day. The increase in liquidity and price momentum suggest renewed interest in the company following its strategic announcements and operational updates during the Bank of America Financial Services Conference earlier in the week.

Strategic and Operational Catalysts

MetLife’s recent performance and strategic direction were highlighted during its presentation at the Bank of America Financial Services Conference 2026. CEO Michel Khalaf and Head of Investment Management John McCallion outlined the “New Frontier” strategy, emphasizing double-digit earnings per share (EPS) growth, a 15%-17% return on equity (ROE) target, and a commitment to reducing the expense ratio by 100 basis points over five years. The company achieved a 40-basis-point reduction in direct expenses in 2025, demonstrating operational efficiency gains. Additionally, the acquisition of PineBridge, finalized in December 2025, boosted MetLife Investment Management’s (MIM) assets under management (AUM) to over $740 billion, enhancing its capabilities in leveraged loans and multi-asset platforms.

International expansion emerged as a critical growth driver. MetLife reported strong momentum in Latin America (LATAM), with a near-term path to $1 billion in earnings, and highlighted diversified distribution and product capabilities in Japan and Korea. The company attributed its success in mature markets to renewed consumer savings behavior, demographic trends, and strategic reinsurance initiatives. For instance, reinsurance transactions with Challenger provided tools to generate assets for MIM, while the integration of PineBridge expanded MetLife’s global reach.

Operational improvements were underscored by technological advancements and cost management. The company leveraged artificial intelligence (AI) to streamline processes, contributing to a 11.7% expense ratio in 2025—well on track to meet the 11.3% target. Khalaf emphasized that AI’s productivity gains would further reduce costs and enhance customer offerings, particularly in leave and absence management, where product bundling and platform investments are driving segment growth.

Financial targets for 2026 include a 9% annualized return on variable investment income and EBITDA growth for MIM from $240 million to $280 million. The company also outlined a path to $1 billion in earnings in LATAM by leveraging embedded insurance and third-party distribution channels. These initiatives align with the New Frontier strategy’s focus on capital management, with a 60-40 split between earnings growth and share repurchases supporting EPS targets.

Challenges, such as persistency pressures in group benefits due to early rate adjustments in 2025, were acknowledged but framed as temporary. Strong 1-1 renewal rates are expected to offset these pressures in the near term. Additionally, MetLife addressed macroeconomic risks, including solvency ratio adjustments in Japan, where it anticipates maintaining a 170-190 ESR ratio by March 2026. The company also noted the potential impact of AI on employment trends but stressed its focus on productivity gains rather than workforce reduction.

The strategic integration of PineBridge and continued international expansion position MetLife to capitalize on its diversified business model. With a clear roadmap for expense reduction, asset management growth, and market penetration, the company’s stock appears poised to benefit from both operational execution and external tailwinds in key geographies. Investors are likely factoring in these developments as the stock’s 2.15% gain suggests optimism about MetLife’s ability to deliver on its ambitious financial and strategic goals.